Objective-To observe the influence of T cell subset changes on the development of experimental arthritis, by using the bacterial superantigen staphylococcal enterotoxin B (SEB) to modulate the T cell repertoire during the arthritogenic response to type II collagen (CII) in vivo. Methods-DBAII mice were injected with SEB before immunisation with CII, and assessed for the development of collagen induced arthritis (CIA) and an immune response to CII. Mice with established arthritis were also treated therapeutically with SEB. Flow cytometry was used to evaluate the effect of the therapy on T cell subsets and T cell receptor (TCR) VD 
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Objective-To observe the influence of T cell subset changes on the development of experimental arthritis, by using the bacterial superantigen staphylococcal enterotoxin B (SEB) to modulate the T cell repertoire during the arthritogenic response to type II collagen (CII) in vivo. Methods-DBAII mice were injected with SEB before immunisation with CII, and assessed for the development of collagen induced arthritis (CIA) and an immune response to CII. Mice with established arthritis were also treated therapeutically with SEB. Flow cytometry was used to evaluate the effect of the therapy on T cell subsets and T cell receptor (TCR) VD expression. Results-Mice injected with SEB developed arthritis significantly faster than saline treated control animals, and developed more severe clinical features. Mice treated with SEB after the onset of CIA were also observed to progress more rapidly to a severe arthritis than mice treated with saline alone. The level ofanti-CII antibody was not affected by SEB injection. Flow cytometric analysis of TCR expression in mice 21 Collagen induced arthritis (CIA) in mice is an experimental disease model which resembles rheumatoid arthritis (RA) with respect to both the histopathological features of arthritis and immunogenetic regulation by the major histocompatibility complex (MHC). A close parallel is observed between the class II MHC (HLA-DR) association in RA and the strict MHC association seen in CIA.' 2 The immunogenetic analysis of susceptibility to CIA in mice indicates that both the MHC (H-2) phenotype and the T cell repertoire may be critical in the development of autoimmunity. Recent evidence has suggested a potential role for the minor lymphocyte stimulating (Mls) genes in CIA susceptibility.3 ' The Mls locus acts in the selection of the T cell repertoire, as T cells that recognise Mls antigens in context with self MHC are clonally deleted in the thymus,5 6 and it has been suggested that a dysfunction in the Mls system may result in the preservation of self reactive T cells. 3 DBA/1 mice (group 1) were prophylactically injected intraperitoneally with 100 pl (40 , Figure 1 shows the effect of SEB injection upon the development of CIA. DBA/1 mice injected with SEB and immunised with collagen developed arthritis significantly faster (mean day of onset 37.4) than control animals injected with saline and immunised with collagen (mean day of onset 56 7) (p < 0 0 1), although the final disease incidence was similar (80%). Mice injected with SEB and immunised with FCA alone did not develop arthritis. Figure 2 shows the effect of SEB on the severity of the arthritis. Mice injected with SEB and immunised with collagen developed a similar number of involved paws, but significantly more severe clinical disease (assessed by the maximum disease index) than control animals (p < 0 02). The arthritis in DBA/1 mice treated with a single injection of SEB 40 ,ug at the onset of disease (fig 3) progressed faster than in control mice treated with saline, with significant differences in the arthritis score occurring from one week after onset and sustained throughout the assessment period (p < 0 05) at week 1, p < 0-02 at week 5). Days after immunisation Figure 1 Effect ofstaphylococcal enterotoxin B (SEB) on the incidence of type II collagen induced arthritis. Groups of 10 DBA/I mice were injected intraperitoneally with 40 ,ug SEB in sterile saline (---), or sterile saline alone (control) (-) at day -1. All mice were immunised with 100 ,ug of bovine type II collagen on day 0, and assessedfor the development of arthritis. In contrast to the analysis 21 days after immunisation, flow cytometric analysis of T cell VP receptor expression in mice sacrificed 70 days after CII immunisation showed no significant variations in the T cell repertoire (VP2, 3, 5, 6, 7, 8, 9, 11, 14) between the enterotoxin treated mice and controls (data not shown). the T cell repertoire using superantigen immunotherapy appeared to represent a viable approach to the treatment of autoimmune disease in which limited TCR usage is responsible for the development of autoimmunity. SEB immunotheraphy has already shown the potential for modulation of murine models of autoimmune disease, with positive effects reported in MRL lpr/lpr disease. 34 In that study, V38 T cells were reduced in both spleen and lymph nodes from MRL lpr/lpr mice, and the SEB therapy resulted in the improvement of both the clinical and immunological features of murine lupus. However, intra-articular injection of SEB in V38.2 transgenic MRL lpr/ lpr mice gave rise to a chronic arthritis,35 suggesting that the chronic joint disease in this model was adversely affected. Our data suggest that staphylococcal enterotoxins were not immunosuppressive in collagen immunised mice at any administration time point examined. DBA/1 mice injected with a single dose of SEB at the time of CII immunisation developed arthritis faster, and exhibited more severe disease signs, than control animals. Administration of SEB subsequent to the appearance of CIA also resulted in a more severe arthritis. The precise cause of the increased disease severity is not clear, as the immune response to collagen was not increased in SEB treated mice. The flow cytometric data indicated changes in both B cells and T cells in enterotoxin treated, CII immunised mice. As predicted by published studies on the in vivo and in vitro effects of enterotoxins, 10 3 34 treatment with SEB before immunisation with CII caused changes in the TCR repertoire of DBA/I mice. These changes in T cell VP expression were detected 21 days after injection of enterotoxin but were not apparent 70 days after injection. A decrease in TCR V18 expression occurred in lymph node cells from both collagen immunised and normal mice in response to SEB injection. 4 However, it is possible also that the effect is independent of specific influences on the T cell repertoire in the DBA/1 mice, as the introduction of enterotoxins in collagen immunised mice may promote increased cytokine activity in synovial cells, 38 and it has been demonstrated that increased levels of interleukins and interferon promote CIA.39"2 Although our data suggest that the anti-collagen antibody levels were not influenced by SEB immunotheraphy, it is possible that the endotoxin may influence the amount of antibody directed against murine type II collagen, which is more closely related to the development of CIA. 43 Further studies are necessary to determine the mechanism by which SEB influences this experimental model of arthritis.
Our results suggest that the concept of T cell modification using superantigen immunotherapy may be problematic, because the T cell subsets modified in vivo did not correlate completely with the predictions based on in vitro studies, and the nature of the specific autoimmune response may be critical to the outcome of the immunotherapy. The precise immunogenetic aspects of the autoimmune disease may also play a crucial role in the outcome, as a similar approach to the treatment of CIA induced by B10.RIII mice using SEB has demonstrated disease suppression.44 However, this H-2r strain responds to a different epitope on the CII molecule,23 and TCR usage in B10.RIII mice immunised with porcine collagen may vary markedly from that in DBA/1 mice injected with bovine collagen. Marked differences between H-2q and H-2r haplotype mice were observed in the response to immunotherapy using monoclonal antibodies directed against the class II MHC molecule, with B10.RIII mice developing a more severe arthritis after the injection of an anti-I-E antibody. 45 At present, the specificity of the T cell autoimmune response in rheumatoid arthritis is unknown, and the response may be directed against several self components. Current reports suggest that the T cell receptor expression in synovial fluid and synovial tissue is polyclonal and varies within the RA population.46-48 It will therefore be important to determine the precise nature of the T cell response in RA patients before a superantigen therapy should be considered in human autoimmune disease. 
